Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease
This study has been completed.
Sponsor:
Takeda
Collaborator:
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):
Takeda
ClinicalTrials.gov Identifier:
NCT00521742
First received: August 25, 2007
Last updated: February 27, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2003 |
| Primary Completion Date: | January 2003 (Final data collection date for primary outcome measure) |